Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Morphogenetic Proteins | 3 | 2023 | 844 | 1.180 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2023 | 343 | 0.730 |
Why?
|
| Avian Proteins | 1 | 2020 | 77 | 0.690 |
Why?
|
| Protein Multimerization | 1 | 2020 | 960 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2902 | 0.340 |
Why?
|
| Signal Transduction | 3 | 2021 | 23619 | 0.210 |
Why?
|
| Heparitin Sulfate | 1 | 2023 | 223 | 0.190 |
Why?
|
| Estrous Cycle | 1 | 2021 | 65 | 0.190 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 104 | 0.180 |
Why?
|
| Crohn Disease | 3 | 2018 | 2286 | 0.170 |
Why?
|
| Myositis Ossificans | 1 | 2020 | 77 | 0.160 |
Why?
|
| Chickens | 1 | 2020 | 842 | 0.150 |
Why?
|
| Fertility | 1 | 2021 | 770 | 0.140 |
Why?
|
| Colitis | 2 | 2015 | 1238 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.120 |
Why?
|
| Surface-Active Agents | 1 | 2014 | 150 | 0.110 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 76 | 0.110 |
Why?
|
| Interleukin-10 | 2 | 2016 | 1182 | 0.110 |
Why?
|
| Ligands | 1 | 2020 | 3275 | 0.110 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 828 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2018 | 3792 | 0.090 |
Why?
|
| Protein Binding | 1 | 2023 | 9320 | 0.090 |
Why?
|
| Cytokines | 3 | 2021 | 7438 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2023 | 4924 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2015 | 2603 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2014 | 1040 | 0.080 |
Why?
|
| Antimalarials | 1 | 2014 | 909 | 0.070 |
Why?
|
| Th17 Cells | 1 | 2014 | 790 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1904 | 0.070 |
Why?
|
| Cell Line | 1 | 2020 | 15563 | 0.070 |
Why?
|
| Malaria, Falciparum | 1 | 2014 | 1075 | 0.060 |
Why?
|
| Ileum | 2 | 2018 | 558 | 0.060 |
Why?
|
| Colon | 3 | 2018 | 1797 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 2014 | 1739 | 0.060 |
Why?
|
| Chromatin | 1 | 2016 | 2977 | 0.060 |
Why?
|
| Macrophages | 2 | 2016 | 5783 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4410 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2014 | 3077 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 16724 | 0.040 |
Why?
|
| Periodicity | 1 | 2021 | 347 | 0.040 |
Why?
|
| Inflammation | 2 | 2016 | 10860 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2039 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18330 | 0.040 |
Why?
|
| Animals | 6 | 2021 | 168930 | 0.040 |
Why?
|
| Ileostomy | 1 | 2018 | 122 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 9525 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 294 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 3041 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6779 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2014 | 90 | 0.030 |
Why?
|
| Thiourea | 1 | 2014 | 68 | 0.030 |
Why?
|
| Naphthoquinones | 1 | 2014 | 60 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 464 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2014 | 244 | 0.030 |
Why?
|
| Plasmodium berghei | 1 | 2014 | 161 | 0.030 |
Why?
|
| Humans | 9 | 2021 | 766766 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 949 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 696 | 0.030 |
Why?
|
| Amines | 1 | 2014 | 280 | 0.030 |
Why?
|
| Mice | 5 | 2021 | 81889 | 0.030 |
Why?
|
| Prognosis | 3 | 2018 | 29948 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 960 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2016 | 14471 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4142 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4570 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2016 | 22248 | 0.020 |
Why?
|
| Reoperation | 1 | 2018 | 4325 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11920 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2325 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 22352 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2018 | 3691 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8507 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2060 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7585 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10745 | 0.010 |
Why?
|
| Female | 5 | 2021 | 396520 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 59550 | 0.010 |
Why?
|
| Male | 5 | 2018 | 364142 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 59939 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18397 | 0.010 |
Why?
|
| Child | 2 | 2018 | 80668 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 88904 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13640 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 223307 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 12806 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41710 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42577 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 171343 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 223257 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65273 | 0.010 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_